Aimei Health Technology Co., Ltd (AFJK)
| Market Cap | 281.51M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | 1.41M |
| Shares Out | 6.12M |
| EPS (ttm) | 0.20 |
| PE Ratio | 227.84 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 24,217 |
| Open | 45.52 |
| Previous Close | 44.89 |
| Day's Range | 43.00 - 62.78 |
| 52-Week Range | 6.75 - 130.37 |
| Beta | -1.50 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 20, 2026 |
About AFJK
Aimei Health Technology Co., Ltd does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other services sector. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York. [Read more]
News
AIMEI HEALTH TECHNOLOGY CO., LTD RECEIVES NASDAQ NOTICE REGARDING DELAYED ANNUAL REPORT
New York, NY, April 21, 2026 (GLOBE NEWSWIRE) -- Aimei Health Technology Co., Ltd (the “Company”) (Nasdaq: AFJK) today announced that on April 17, 2026, it received a notice (the “Notice”) from the Li...
China's United Hydrogen to list on Nasdaq via $1.6 bln blank-check deal
Green energy company United Hydrogen Group said on Thursday it would be listing its shares on the Nasdaq via a blank-check merger that values the company at $1.6 billion.